HighQC™ IPSC FFGAU AcceGen

HighQC™ IPSC FFGAU

0.01 EURAsk for quotation

On request

quantity

Produktdetaljer

Katalognummer: 870 - ABC-SC2107

Produktkategori: Företag och industri > Vetenskap och laboratorium

Leverantör:

Parameters

Storage and shipping	Liquid Nitrogen

ABC-SC2107

IPSC (induced Pluripotent Stem cells) reprogrammed from human Fibroblasts of a Gaucher Syndrome (Morbus Gaucher) patientThis iPS cell line was created using a normal human fibroblast derived from tissue of a male infant suffering from Gaucher Syndrom (Morbus Gaucher).The iPS cell line was generated using an episomal reprogramming containing a prprietary mix of vectors, containing Oct-4, Sox-2, Klf-4 along with p53 Anti-sense, EBNA-1.The cell line was validated for pluripotency based on colony morphology, alkaline phosphatase expression, and expression of SSEA-4.iPS colonies exhibit classical morphology and growth.

Ask for quotation

ABC-SC2108

HighQC™ IPSC Human Foreskin Fibroblast IPSC FFHFF

IPSC human Foreskin FibroblastPassage: 1500,000 cellsThis iPS cell line was created using a normal human foreskin fibroblast.The iPS cell line was generated using an episomal reprogramming containing a prprietary mix of vectors, containing Oct-4, Sox-2, Klf-4 along with p53 Anti-sense, EBNA-1.Thus, a newborn foreskin fibroblast was reprogrammed into induced pluripotent stem cells (iPSC).The cell line was validated for pluripotency based on colony morphology, alkaline phosphatase expression, and expression of SSEA-4.iPS colonies exhibit classical morphology and growth.Absence of Mycoplasma was confirmed.The cell line is shipped on dry ice.

Ask for quotation

ABC-SC2027

HighQC™ Human IPSC From Fibroblast

Open Sans, Helvetica Neue, Helvetica, Arial, sans-serif. These pluripotent cells were generated from normal human skin fibroblasts using episomal reprogramming methods.andamp;nbsp; This method allows the transient expression of human transcription factors (OCT4, SOX2, KLF4, and c-MYC) that initiate the reprogramming process.

Ask for quotation

ABC-SC0006T

HighQC™ Human IPS Cell (IPSC From Fibroblast/ Parkinson/ Episomal)

Induced Pluriopotent Stem Cells (iPSCs) are a type of pluripotent stem cells that can be derived directly from adult somatic cells .The derived iPSCs can propagate indefinitely, as well as give rise to other cell types in the body. iPS cells, thus, hold great promise in the field of regenerative medicine by representing a single source of cells that could be used to replace those damaged/diseased cells. Gentaur is proud to offer human iPS cell lines derived from the human somatic cells (dermal fibroblasts, adipose-derived stem cells, peripheral blood mononuclear cells) from patients with Parkinson's Disease (PD). The pertinent donor information is available upon request. These iPS cells are established from a single clone and expanded in feeder-free conditions. Normal human iPS cell lines are also available as separate products. We also provide custom iPSC generation and iPSC differentiation services to meet your needs.

Ask for quotation

ABC-SC2042

HighQC™ Human IPSC From Fibroblast-Apparently Healthy Individual

Apparently Healthy Individual; Subcollection: Apparently healthy iPSCsApparently Healthy Collection; Affected: NO; Cells are only guaranteed with purchase of Gentaur Media and Gentaur Extra Cellular Matrix for appropriate cell culture, for 30 days from the date of shipment.

Ask for quotation

ABC-SC0069T

HighQC™ Human IPSC-Derived Neural Stem Cell MAPT R406W HOM

Human Human IPSC-Derived Neural Stem Cells that have been genetically edited using CRISPR-Cas9 technology to introduce the R406W mutation (CGGandgt;TGG) into the MAPT gene. This line is homozygous for the R406W mutation so both alleles contain the mutation. The R406W mutation in MAPT has been implicated in familial frontotemporal dementia and parkinsonism (Hutton et al., 1998; Behnam et al., 2015) and has been seen in patients with clinical presentation resembling Alzheimer's disease (Rademakers et al., 2003; Lindquist et al., 2008). The R406W mutation reduces the ability of MAPT/tau to bind to microtubules in vitro (Hong et al., 1998).

Ask for quotation

Håll dig uppdaterad! Visa tidigare publikationer

By: Author , 2 Comment